Idelalisib in indolent NHL - has it finally found its niche?

Leuk Lymphoma. 2021 May;62(5):1029-1030. doi: 10.1080/10428194.2020.1836369. Epub 2020 Oct 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Follow-Up Studies
  • Humans
  • Lymphoma, Non-Hodgkin*
  • Purines
  • Quinazolinones* / adverse effects

Substances

  • Purines
  • Quinazolinones
  • idelalisib